Monsanto and Bayer Maneuvers to Take Over the Cannabis Industry

Monsanto: The name strikes fear into food-conscious individuals in many parts of the United States and abroad. Well-known for their constant genetic tampering with food industries (corn and soy, in particular), the corporate giant has set its eyes on another area: Cannabis. The ganja we know and love may soon be a shadow of the beautiful plant we became so well-acquainted with in high school.

Increasingly frequently, evidence is mounting that Monsanto may desire a hold on our doobies even though it has claimed otherwise. Last September, Bayer bought out Monsanto for $66 billion, marking a merger that could be catastrophic for anyone whose daily activities include getting high as a kite.

Sadly, Bayer and Monsanto both may have ties to Nazis. With a robust history of development of chemical weapons, Bayer — formerly IG Farben, developer of chemical weapons used on Jews during the Nazi era — these two companies seem to be up to no good. Unless we want our tokin’ to come with a hint of radical fascism, it may be time to draw the line.

You see, after the Nuremberg Trials, IG Farben had a number of top executives sent to prison for crimes against humanity — totally not a cool thing to contemplate while getting a buzz on. Shortly after their imprisonment, many of them began filling positions at the IG Farben off-shoots… Including Bayer. The Alliance for Human Research Protection has this to say about it:

“IG (Interessengemeinschaft) stands for “Association of Common Interests”: The IG Farben cartel included BASF, Bayer, Hoechst, and other German chemical and pharmaceutical companies. As documents show, IG Farben was intimately involved with the human experiment atrocities committed by Mengele at Auschwitz. A German watchdog organization, the GBG Network, maintains copious documents and tracks Bayer Pharmaceutical Activities.”

Soon, your weed may be super-powered — and super-poisonous.

See, Monsanto and Miracle-Gro have a business partnership. Hawthorne, a front for Miracle-Gro, has already bought three of the biggest canna-heads in the business: Botanicare, Gavita, and General Hydroponics. Many other companies have also received offers of buy-outs, but refused.

“They want to bypass hydroponics retail stores… When we said we won’t get in bed with them, they said ‘Well, we could just buy your whole company like we did with Gavita and do whatever we want.’” said a Hydroponics Lighting Representative.

Miracle-Gro’s CEO has gone so far as to announce his plans for reefer referendums: to “invest, like, half a billion in [taking over] the pot business… It is the biggest thing I’ve ever seen in lawn and garden.” (source)

What’s worse, Monsanto and Bayer are talking about producing GMO marijuana.

Soon, your believed toke could be taken to a place it’s never wanted to be: Our natural medicine, turned Frankenstein on the vine. Michael Straumietis of Advanced Nutrients warns against this:

“Monsanto and Bayer share information about genetically modifying crops. Bayer partners with GW Pharmaceuticals, which grows its own proprietary marijuana genetics. It’s logical to conclude that Monsanto and Bayer want to create GMO marijuana.”

Mary Jane might be going the way of the dinosaur.

Or, at least, our time of it being a naturally healing product that scientists hadn’t tampered with. See, it’s possible that Bayer and Monsanto could create a monopoly on marijuana seeds, just like they have with soy and corn. With the huge amount of money at their disposal, laws just don’t quite work the same way for them — being more of a small hurdle than a wall.

We could probably boycott GMO products, but that seems almost like a waste of time. No, what the weed industry needs is what it’s always had: Dedicated enthusiasts who grow their own. It’s the safest way to get out of the corporate supply chain, and the finest way to ensure a proper relationship with a plant that does so much good for so many people.

See the article that inspired this one here.

Leave a Reply

Your email address will not be published.